Evidence map›Paper›PMID 36936157›Full record

ReviewFrontiers in endocrinology2023

An overview of traditional Chinese medicine affecting gut microbiota in obesity.

Donghui Li, Weiwei Tang, Yanyan Wang, Qi Gao, Hongwei Zhang, Yu Zhang, Yuliang Wang, Yongyi Yang, Yingming Zhou, Yike Zhang and 3 more

Open access · goldFull text readReview
In one paragraph

Review in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Gut Microbiota-Mediated Mechanisms of Traditional Chinese Medicine in Obesity Management.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Mechanisms of action and applications ofFrontiers in pharmacology · 2024
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Donghui LiCollege of Pharmacy, Jiamusi University, Jiamusi, China.
Weiwei TangCollege of Pharmacy, Jiamusi University, Jiamusi, China.
Yanyan WangCollege of Pharmacy, Jiamusi University, Jiamusi, China.
Qi GaoCollege of Pharmacy, Jiamusi University, Jiamusi, China.
Hongwei ZhangDepartment of Emergency Surgery, The First Affiliated Hospital of Jiamusi University, Jiamusi, China.
Yu ZhangCollege of Pharmacy, Jiamusi University, Jiamusi, China.
Yuliang WangCollege of Pharmacy, Jiamusi University, Jiamusi, China.
Yongyi YangCollege of Pharmacy, Jiamusi University, Jiamusi, China.
Yingming ZhouCollege of Pharmacy, Jiamusi University, Jiamusi, China.
Yike ZhangCollege of Pharmacy, Jiamusi University, Jiamusi, China.
Haonan LiCollege of Pharmacy, Jiamusi University, Jiamusi, China.
Shuo LiCollege of Pharmacy, Jiamusi University, Jiamusi, China.
Hong ZhaoCollege of Pharmacy, Jiamusi University, Jiamusi, China.
Jiamusi University · CNFirst Affiliated Hospital of Jiamusi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity, a chronic metabolic disease with a complex pathophysiology, is caused by several variables. High-fat diets lead to the disruption of the gut microbiota and impaired gut barrier function in obese people. The dysbiosis and its metabolites through the intestinal barrier lead to an imbalance in energy metabolism and inflammatory response, which eventually contributes to the development of chronic diseases such as diabetes, hypertension, and cardiovascular disease. Current medicines are therapeutic to obesity in the short term; however, they may bring significant physical and emotional problems to patients as major side effects. Therefore, it is urgent to explore new therapeutic methods that have definite efficacy, can be taken for a long time, and have mild adverse effects. Numerous studies have demonstrated that traditional Chinese medicine (TCM) can control the gut microbiota in a multi-targeted and comprehensive manner, thereby restoring flora homeostasis, repairing damaged intestinal mucosal barriers, and eventually curbing the development of obesity. The active ingredients and compounds of TCM can restore the normal physiological function of the intestinal mucosal barrier by regulating gut microbiota to regulate energy metabolism, inhibit fat accumulation, affect food appetite, and reduce intestinal mucosal inflammatory response, thereby effectively promoting weight loss and providing new strategies for obesity prevention and treatment. Although there are some studies on the regulation of gut microbiota by TCM to prevent and treat obesity, all of them have the disadvantage of being systematic and comprehensive. Therefore, this work comprehensively describes the molecular mechanism of obesity mediated by gut microbiota based on the research state of obesity, gut microbiota, and TCM. A comprehensive and systematic summary of TCM targeting the regulation of gut microbiota for the treatment of obesity should be conducted in order to provide new strategies and ideas for the treatment of obesity.

Indexed as

Drugs, Chinese HerbalGastrointestinal MicrobiomeHumansMedicine, Chinese TraditionalObesityWeight LossDrugs, Chinese Herbalactive ingredientsgut microbiotaobesityshort-chain fatty acids (SCFAs)traditional Chinese medicine

Identifiers

PMID36936157
PMCPMC10016694
OpenAlexW4322744078

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read3
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.